{
  "symbol": "SUNPHARMA.NS",
  "period": "quarterly",
  "data": [
    {
      "ticker": "SUNPHARMA.NS",
      "date": "2024-03-31",
      "quarter": "Q1 2024",
      "fiscal_year": 2024,
      "revenue": null,
      "gross_profit": null,
      "operating_income": null,
      "ebitda": null,
      "net_income": null,
      "diluted_eps": null,
      "total_assets": 854996500000.0,
      "total_liabilities": 183737100000.0,
      "total_equity": 671259400000.0,
      "total_debt": 32736700000.0,
      "cash_and_equivalents": 92856500000.0,
      "current_assets": 434749800000.0,
      "current_liabilities": 169844000000.0,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 40.002293,
      "peg_ratio": null,
      "pb_ratio": 5.3778253,
      "ps_ratio": 7.6169834,
      "price_target_high": 2450.0,
      "price_target_low": 1570.0,
      "price_target_avg": 1950.6842,
      "promoter_holding": 0.55611,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 5.5,
      "splits": 2.0,
      "buybacks": 2399334970,
      "debt_to_equity": 0.048769074965654115,
      "current_ratio": 2.559700666493959,
      "operating_margin": null,
      "net_profit_margin": null,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": null
    },
    {
      "ticker": "SUNPHARMA.NS",
      "date": "2024-06-30",
      "quarter": "Q2 2024",
      "fiscal_year": 2024,
      "revenue": 125245100000.0,
      "gross_profit": 98490800000.0,
      "operating_income": 30029400000.0,
      "ebitda": 41401700000.0,
      "net_income": 28356200000.0,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 40.002293,
      "peg_ratio": null,
      "pb_ratio": 5.3778253,
      "ps_ratio": 7.6169834,
      "price_target_high": 2450.0,
      "price_target_low": 1570.0,
      "price_target_avg": 1950.6842,
      "promoter_holding": 0.55611,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 5.5,
      "splits": 2.0,
      "buybacks": 2399334970,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": 23.976506865338447,
      "net_profit_margin": 22.6405663774471,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 33.056542731013025
    },
    {
      "ticker": "SUNPHARMA.NS",
      "date": "2024-09-30",
      "quarter": "Q3 2024",
      "fiscal_year": 2024,
      "revenue": 132642200000.0,
      "gross_profit": 105700200000.0,
      "operating_income": 31849600000.0,
      "ebitda": 42929600000.0,
      "net_income": 30401600000.0,
      "diluted_eps": null,
      "total_assets": 881156600000.0,
      "total_liabilities": 187360100000.0,
      "total_equity": 693796500000.0,
      "total_debt": 25719500000.0,
      "cash_and_equivalents": 80125400000.0,
      "current_assets": 461054500000.0,
      "current_liabilities": 172552200000.0,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 40.002293,
      "peg_ratio": null,
      "pb_ratio": 5.3778253,
      "ps_ratio": 7.6169834,
      "price_target_high": 2450.0,
      "price_target_low": 1570.0,
      "price_target_avg": 1950.6842,
      "promoter_holding": 0.55611,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 5.5,
      "splits": 2.0,
      "buybacks": 2399334970,
      "debt_to_equity": 0.03707066841645929,
      "current_ratio": 2.6719711484408775,
      "operating_margin": 24.011664462742626,
      "net_profit_margin": 22.920005850325158,
      "roe": 4.381918905615696,
      "roa": 3.450192621833622,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 32.36496378980445
    },
    {
      "ticker": "SUNPHARMA.NS",
      "date": "2024-12-31",
      "quarter": "Q4 2024",
      "fiscal_year": 2024,
      "revenue": 134369400000.0,
      "gross_profit": 106964000000.0,
      "operating_income": 35618100000.0,
      "ebitda": 41584700000.0,
      "net_income": 29033800000.0,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 40.002293,
      "peg_ratio": null,
      "pb_ratio": 5.3778253,
      "ps_ratio": 7.6169834,
      "price_target_high": 2450.0,
      "price_target_low": 1570.0,
      "price_target_avg": 1950.6842,
      "promoter_holding": 0.55611,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 5.5,
      "splits": 2.0,
      "buybacks": 2399334970,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": 26.507597711979063,
      "net_profit_margin": 21.60744931509704,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 30.948043230080657
    },
    {
      "ticker": "SUNPHARMA.NS",
      "date": "2025-03-31",
      "quarter": "Q1 2025",
      "fiscal_year": 2025,
      "revenue": 128155800000.0,
      "gross_profit": 87282400000.0,
      "operating_income": 28314900000.0,
      "ebitda": 39672800000.0,
      "net_income": 21498800000.0,
      "diluted_eps": null,
      "total_assets": 921005800000.0,
      "total_liabilities": 196146300000.0,
      "total_equity": 724859500000.0,
      "total_debt": 23621900000.0,
      "cash_and_equivalents": 102687700000.0,
      "current_assets": 526244700000.0,
      "current_liabilities": 181942100000.0,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 40.002293,
      "peg_ratio": null,
      "pb_ratio": 5.3778253,
      "ps_ratio": 7.6169834,
      "price_target_high": 2450.0,
      "price_target_low": 1570.0,
      "price_target_avg": 1950.6842,
      "promoter_holding": 0.55611,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 5.5,
      "splits": 2.0,
      "buybacks": 2399334970,
      "debt_to_equity": 0.032588246411890856,
      "current_ratio": 2.892374552124,
      "operating_margin": 22.09412293474037,
      "net_profit_margin": 16.775518548516725,
      "roe": 2.965926500239012,
      "roa": 2.334274116406216,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 30.956694897928926
    },
    {
      "ticker": "SUNPHARMA.NS",
      "date": "2025-06-30",
      "quarter": "Q2 2025",
      "fiscal_year": 2025,
      "revenue": 137860700000.0,
      "gross_profit": 109713100000.0,
      "operating_income": 33720700000.0,
      "ebitda": 39481200000.0,
      "net_income": 22786300000.0,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 40.002293,
      "peg_ratio": null,
      "pb_ratio": 5.3778253,
      "ps_ratio": 7.6169834,
      "price_target_high": 2450.0,
      "price_target_low": 1570.0,
      "price_target_avg": 1950.6842,
      "promoter_holding": 0.55611,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 5.5,
      "splits": 2.0,
      "buybacks": 2399334970,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": 24.459980255431752,
      "net_profit_margin": 16.528495793217356,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 28.638473473586018
    }
  ]
}